Edition:
United Kingdom

bluebird bio Inc (BLUE.OQ)

BLUE.OQ on NASDAQ Stock Exchange Global Select Market

119.40USD
4:57pm GMT
Change (% chg)

$2.91 (+2.50%)
Prev Close
$116.49
Open
$115.44
Day's High
$119.66
Day's Low
$114.45
Volume
51,071
Avg. Vol
219,375
52-wk High
$236.05
52-wk Low
$102.35

Chart for

About

bluebird bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. The Company's clinical... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $5,824.04
Shares Outstanding(Mil.): 45.59
Dividend: --
Yield (%): --

Financials

  BLUE.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -7.36 -- --
ROI: -25.26 -0.29 14.22
ROE: -29.40 0.40 15.99

BRIEF-FDA Grants Breakthrough Therapy Designation To Lenti-D For The Treatment Of Cerebral Adrenoleukodystrophy

* FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION TO LENTI-D™ FOR THE TREATMENT OF CEREBRAL ADRENOLEUKODYSTROPHY

23 May 2018

Earnings vs. Estimates